An in-house health care veteran is soon joining AcelRx Pharmaceuticals Inc. as its top lawyer, months after the U.S. Food and Drug Administration rejected the company’s pain medication Dsuvia.

The Redwood City, California-based AcelRx has named John Saia as its new general counsel, effective April 16, according to a company statement. Saia joins AcelRx after 11 years at McKesson Corp., most recently as the giant drug distributor’s corporate secretary and associate GC.